Clinical Trials Browser

Phase 1 × tepotinib × 90 days × Clear all

NCT07619339 2026-06-02

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05782361 2026-04-24

POTENT

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms